» Articles » PMID: 25064566

Kotai Antibody Builder: Automated High-resolution Structural Modeling of Antibodies

Overview
Journal Bioinformatics
Specialty Biology
Date 2014 Jul 28
PMID 25064566
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Kotai Antibody Builder is a Web service for tertiary structural modeling of antibody variable regions. It consists of three main steps: hybrid template selection by sequence alignment and canonical rules, 3D rendering of alignments and CDR-H3 loop modeling. For the last step, in addition to rule-based heuristics used to build the initial model, a refinement option is available that uses fragment assembly followed by knowledge-based scoring. Using targets from the Second Antibody Modeling Assessment, we demonstrate that Kotai Antibody Builder generates models with an overall accuracy equal to that of the best-performing semi-automated predictors using expert knowledge.

Availability And Implementation: Kotai Antibody Builder is available at http://kotaiab.org

Contact: standley@ifrec.osaka-u.ac.jp.

Citing Articles

How can we discover developable antibody-based biotherapeutics?.

Bauer J, Rajagopal N, Gupta P, Gupta P, Nixon A, Kumar S Front Mol Biosci. 2023; 10:1221626.

PMID: 37609373 PMC: 10441133. DOI: 10.3389/fmolb.2023.1221626.


Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens.

Guarra F, Colombo G J Chem Theory Comput. 2023; 19(16):5315-5333.

PMID: 37527403 PMC: 10448727. DOI: 10.1021/acs.jctc.3c00513.


Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.

Wilman W, Wrobel S, Bielska W, Deszynski P, Dudzic P, Jaszczyszyn I Brief Bioinform. 2022; 23(4).

PMID: 35830864 PMC: 9294429. DOI: 10.1093/bib/bbac267.


A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.

Hsieh Y, Liao J, Chuang K, Ho K, Hong S, Liu H J Nanobiotechnology. 2022; 20(1):58.

PMID: 35101043 PMC: 8805405. DOI: 10.1186/s12951-022-01259-2.


DLAB: deep learning methods for structure-based virtual screening of antibodies.

Schneider C, Buchanan A, Taddese B, Deane C Bioinformatics. 2021; 38(2):377-383.

PMID: 34546288 PMC: 8723137. DOI: 10.1093/bioinformatics/btab660.